Myriad Genetics | MYGN - Assets


Myriad Genetics reported $638.9M in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Agilent USD 13.97B 902M Jun/2026
Becton, Dickinson and Co. USD 50.73B 101M Jun/2026
Bio-Rad Laboratories USD 10.25B 462M Jun/2026
Bruker USD 6.05B 77.8M Jun/2026
Danaher USD 92.37B 8.82B Jun/2026
Illumina USD 6.65B 91M Jun/2026
J&J USD 201.06B 167M Jun/2026
Mettler Toledo International USD 3.67B 2.03M Jun/2026
Myriad Genetics USD 638.9M 34.8M Jun/2026
OraSure Technologies USD 360.55M 18.62M Jun/2026
Pacific Biosciences Of California USD 751.85M 30.51M Jun/2026
Quest Diagnostics USD 16.94B 266M Jun/2026
Quidel USD 5.72B 86.6M Jun/2026
Repligen USD 2.95B 19.41M Jun/2026
Revvity USD 12.05B 49.24M Jun/2026
Standard Biotools USD 639.11M 71.36M Mar/2026
Thermo Fisher Scientific USD 113.17B 107M Jun/2026
Veracyte USD 1.49B 49.97M Jun/2026
Waters USD 24.75B 220M Jun/2026